Tokyo, Japan

Kaori Nishio

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Discoveries of Kaori Nishio in Cancer Detection

Introduction

Kaori Nishio is a prominent inventor based in Tokyo, Japan, known for her groundbreaking work in the field of cancer detection. With one registered patent to her name, Nishio has made significant contributions towards the accurate evaluation of tumor cells, aiming to enhance cancer diagnosis and treatment.

Latest Patents

Nishio's patent, titled "Apparatus for detecting the degree of malignancy of each of circulating tumor cells," addresses a critical need in oncology. The invention provides a sophisticated evaluation method that can accurately determine the metastasis of cancer, the stage of cancer progression, and the malignancy of cancer. This method involves steps such as bringing in contact an epithelial cell-binding component and a mesenchymal cell-binding component with a sample that may contain circulating tumor cells. By detecting fluorescence or luminescence signals from these components, it enables assessment of the degree of epithelial-mesenchymal transition in the cells.

Career Highlights

Throughout her career, Kaori Nishio has worked with prestigious organizations, including On-chip Biotechnologies Co., Ltd. and the Shizuoka Prefecture. Her experiences in these firms have significantly influenced her research and innovation capabilities, allowing her to develop effective solutions for complex biological problems.

Collaborations

Nishio has collaborated with notable colleagues like Kazuo Takeda and Namiko Yamashita. These partnerships have fostered a collaborative environment that enhances innovation and leads to the development of new methodologies in cancer detection.

Conclusion

Kaori Nishio's contributions to the field of cancer research illuminate the crucial intersection of technology and healthcare. Her innovative patent for detecting malignancy in circulating tumor cells is a testament to her dedication and expertise, promising to facilitate better cancer diagnostics and ultimately improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…